Richard Lifton and Marc Tessier-Lavigne
Rockefeller University has appointed Richard Lifton as its 11th president. He is currently a professor of internal medicine and genetics at Yale University, and founded the Yale Center for Genome Analysis where he has served as executive director since its creation. Lifton has been a Howard Hughes Medical Institute investigator since 1994, and he co-chaired the planning committee for President Obama's Precision Medicine Initiative in 2015. He will succeed Marc Tessier-Lavigne, who is leaving Rockefeller to become Stanford University's next president.
ImmunArray has appointed Dick Aderman to its board of directors. Aderman is currently the president and CEO of Hycor Biomedical and has held both positions since 2010. He previously served as president of Given Imaging, and president and chief operating officer of Quadraspec. He also spent eight years on the senior management team at Roche Diagnostics, and held various positions in sales, marketing, and management with American Hospital, Baxter Healthcare, and Dade International.
OpGen has appointed Harry D'Andrea to its board of directors. D'Andrea is currently a managing general partner of Valhalla Partners. From 1999 to 2002, he was CFO of Advanced Switching Communications. D'Andrea held senior financial positions with a number of private and public companies from 1989 to 1999. He was also a member of the Nasdaq Listings Qualification Panel from 2004 to 2014.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.